Routine Use of Bivalirudin Reduces Bleeding and Increases Ischemic Complications During Percutaneous Coronary Intervention

被引:0
|
作者
Yarkoni, Alon [1 ]
Kini, Annapoorna S. [1 ]
Krishnan, Prakash [1 ]
Kim, Michael C. [1 ]
Moreno, Pedro R. [1 ]
Kodali, Visali [1 ]
Sharma, Samin S. [1 ]
机构
[1] Mt Sinai Hosp, New York, NY 10029 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S934 / S935
页数:2
相关论文
共 50 条
  • [1] BLEEDING COMPLICATIONS WITH PERCUTANEOUS CORONARY INTERVENTION: A COMPARISON OF BIVALIRUDIN AND EPTIFIBATIDE
    Kohli, S.
    Campbell, R. J.
    Kjelsberg, M. A.
    Saal, A. K.
    CARDIOLOGY, 2013, 125 : 429 - 429
  • [2] Heparin, bivalirudin, and reduction of complications during percutaneous coronary intervention
    Nappi, J
    PHARMACOTHERAPY, 2002, 22 (06): : 89S - 89S
  • [3] Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention†
    Iijima, Raisuke
    Ndrepepa, Gjin
    Mehilli, Julinda
    Byrne, Robert A.
    Schulz, Stefanie
    Neumann, Franz-Josef
    Richardt, Gert
    Berger, Peter B.
    Schoemig, Albert
    Kastrati, Adnan
    EUROPEAN HEART JOURNAL, 2009, 30 (03) : 290 - 296
  • [4] The impact of bivalirudin on percutaneous coronary intervention-related bleeding
    Lindsey, Jason B.
    Cohen, David J.
    Stolker, Joshua M.
    Mehta, Sameer K.
    Mahoney, Elizabeth
    Robertus, Katherine
    House, John A.
    Kennedy, Kevin
    Riggs, Lisa
    Rao, Sunil V.
    Marso, Steven P.
    EUROINTERVENTION, 2010, 6 (02) : 206 - 213
  • [5] Exploration of bivalirudin use during percutaneous coronary intervention for high bleeding risk patients with chronic total occlusion
    Li, Chenguang
    Ge, Junbo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : B309 - B309
  • [6] Exploration of Bivalirudin Use during Percutaneous Coronary Intervention for High Bleeding Risk Patients with Chronic Total Occlusion
    Li, Chenguang
    Shen, Yi
    Xu, Rende
    Dai, Yuxiang
    Chang, Shufu
    Lu, Hao
    Ge, Lei
    Ma, Jianying
    Qian, Juying
    Ge, Junbo
    INTERNATIONAL HEART JOURNAL, 2018, 59 (02) : 293 - 299
  • [7] Body mass index and bleeding complications after percutaneous coronary intervention: Does bivalirudin make a difference?
    Delhaye, Cedric
    Wakabayashi, Kohei
    Maluenda, Gabriel
    Belle, Loic
    Ben-Dor, Itsik
    Gonzalez, Manuel A.
    Gaglia, Michael A., Jr.
    Torguson, Rebecca
    Xue, Zhenyi
    Suddath, William O.
    Satler, Lowell F.
    Kent, Kenneth M.
    Lindsay, Joseph
    Pichard, Augusto D.
    Waksman, Ron
    AMERICAN HEART JOURNAL, 2010, 159 (06) : 1139 - 1146
  • [8] Bivalirudin during percutaneous coronary intervention in acute coronary syndromes
    Laine, Marc
    Lemesle, Gilles
    Dabry, Thibaut
    Panagides, Vassili
    Peyrol, Michael
    Paganelli, Franck
    Bonello, Laurent
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (03) : 295 - 304
  • [9] Bivalirudin in percutaneous coronary intervention
    Caron, MF
    McKendall, GR
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (18) : 1841 - 1849
  • [10] Bivalirudin use during percutaneous coronary intervention in patients on chronic warfarin therapy
    Kiviniemi, Tuomas
    Karjalainen, Pasi
    Niemela, Matti
    Rubboli, Andrea
    Lip, Gregory Y. H.
    Schlitt, Axel
    Nammas, Wail
    Airaksinen, K. E. Juhani
    THROMBOSIS RESEARCH, 2014, 133 (04) : 695 - 696